Cardiology

Cardiac Science Reports Fourth Quarter and Full Year 2006 Results

Published in Cardiovascular Business Week, March 13th, 2007

Cardiac Science Corporation (NASDAQ:CSCX), a global leader in external cardiac monitoring and defibrillation products, announced financial results for the fourth quarter and full year ended December 31, 2006.

Revenue for the fourth quarter increased 9% to $39.0 million from revenue for the fourth quarter of 2005 of $35.9 million. The growth reflected a 41% increase in defibrillation sales, partially offset by an 11% decline in cardiac monitoring revenue. Domestic AED sales rose 50% from the prior year's fourth quarter and international AED sales increased 31%, despite a temporary decline in sales in Japan due to the transition to a recently-introduced AED product. The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2007-03-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry